The proposed bill aims to expand the Right to Try Act by removing existing restrictions on patients who are eligible to receive experimental medications. This change is intended to provide greater access to potentially life-saving treatments for patients with serious or terminal illnesses who have exhausted all other options.

Additionally, the bill seeks to extend governmental immunity related to the Right to Try Act, which may protect healthcare providers and manufacturers from legal liability when patients access experimental treatments. The bill includes amendments to multiple sections of the Montana Code Annotated (MCA), specifically sections 50-12-102 through 50-12-110, to implement these changes.

Statutes affected:
SB0422_1.pdf: 50-12-102, 50-12-103, 50-12-104, 50-12-105, 50-12-106, 50-12-107, 50-12-108, 50-12-109, 50-12-110
Introduced: 50-12-102, 50-12-103, 50-12-104, 50-12-105, 50-12-106, 50-12-107, 50-12-108, 50-12-109, 50-12-110